[Corrections] Correction to Lancet Oncol 2017; 18: 1182–91

Overman MJ, McDermott R, Leach JL, et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol 2017; 18: 1182–91—In this Article, in the Findings section of the Summary, and in the Results section of the main paper, "Kaplan-Meier 12-month estimate" should have been stated before the estimate "86%, 95% CI 62–95". In the Results section of the main paper, the earlier database lock date should have been September, 2016.

http://ift.tt/2gxeTfa